Now Entering Russ's World
Clay Siegall is the CEO and Founder of the Seattle Genetics Company. Clay Siegall founded the Seattle Genetics Company in 1998. Clay Siegall is also the CEO and President of Seattle Genetics. He is a scientist who is trained with emphasis to target cancer therapies. Clay Siegall founded the company with the main purpose of extending his numerous scientific innovations that aid in the fight against cancer. He hopes that one day he will find the cure for cancer in the Seattle Genetics laboratories. Clay Siegall’s main purpose for founding the Seattle Genetics Company was to extend his research to the development practices of cancer drugs as well as his passion for becoming part of the solution to the problems the clients face.
Clay Siegall has guided the Seattle Genetics Company towards the development of the drug conjugates for cancer antibodies. FDA has approved these drugs as safe for treatment and human medication under the prescription of a qualified doctor. Clay Siegall has also collaborated with some companies through the use of Seattle Genetics such as the Takeda Pharmaceutical to become approved in more than 80 countries in the world. Clay Siegall is also working to develop a wide range of drugs that can be used to treat cancer.
Under the leadership of Clay Siegall, the Seattle Genetics Company has been approved for numerous strategic licenses for their technology to develop cancer drugs. Clay Siegall has also helped the Seattle Genetics Company generate more than $300 million because of their solutions to the cancer patients in the world. More than 40 cancer clinics are employing the use of Seattle Genetics drugs for treating their patients all over the industry. Clay Siegall has also led the company towards raising enough capital to sustain its business deals in many ways.
Before he founded the Seattle Genetics Company, Clay Siegall worked with the Squibb Pharmaceuticals for over one decade of professional experience in the industry. He used the gathered knowledge and experience to develop the Seattle Genetics Company. Clay Siegall has also received a wide range of awards in the medical industry as well as in business.